We are live on ! Find out more
Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘17
GIGB icon
1001
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$973M
0 2 2 10.2%
LRMR icon
1002
Larimar Therapeutics
LRMR
$432M
0 17 17 90.2%
FTXH icon
1003
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$931M
0 1 1 97.7%